The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1320
ISSUE 1320
September 7, 2009
Issue 1320
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Prasugrel (Effient) vs. Clopidogrel (Plavix)
September 7, 2009 (Issue: 1320)
The FDA has approved prasugrel (Effient - Lilly/Daiichi Sankyo), an oral antiplatelet drug, for use with aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndromes (ACS) being managed with percutaneous...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.